NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Autodesk, Inc. (NASDAQ: ADSK) between June 1, 2023 and April 16, 2024, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff

NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and April 26, 2024, both dates inclusive (the “Class

NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and December 8, 2023, both dates inclusive (the “Class Period”), of the important May 28, 2024 lead

NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds acquirers of a short position in Barclays’ iPath Series B S&P 500 VIX Short-Term Futures Exchange Traded Note (“ETN”) under the symbol “VXXB” (hereinafter “VXX”) due to selling VXX ETNs, selling

NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of AXT, Inc. (NASDAQ: AXTI) between March 24, 2021 and April 3, 2024, both dates inclusive (the